Orchard Capital Management’s Heron Therapeutics HRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.37M | Sell |
659,933
-771,825
| -54% | -$1.6M | 1.51% | 24 |
|
|
2025
Q1 | $3.15M | Sell |
1,431,758
-444,702
| -24% | -$978K | 2.15% | 23 |
|
|
2024
Q4 | $2.84M | Sell |
1,876,460
-103,738
| -5% | -$157K | 1.12% | 29 |
|
|
2024
Q3 | $3.95M | Sell |
1,980,198
-263,228
| -12% | -$525K | 1.36% | 30 |
|
|
2024
Q2 | $7.85M | Sell |
2,243,426
-28,457
| -1% | -$99.6K | 2.37% | 21 |
|
|
2024
Q1 | $6.29M | Buy |
2,271,883
+28,457
| +1% | +$78.8K | 1.85% | 31 |
|
|
2023
Q4 | $3.81M | Buy |
2,243,426
+100,603
| +5% | +$171K | 1.19% | 34 |
|
|
2023
Q3 | $2.21M | Buy |
2,142,823
+751,743
| +54% | +$774K | 0.82% | 36 |
|
|
2023
Q2 | $1.61M | Hold |
1,391,080
| – | – | 0.54% | 37 |
|
|
2023
Q1 | $2.1M | Hold |
1,391,080
| – | – | 0.7% | 36 |
|
|
2022
Q4 | $3.48M | Hold |
1,391,080
| – | – | 1.17% | 35 |
|
|
2022
Q3 | $5.87M | Buy |
1,391,080
+365,056
| +36% | +$1.54M | 2.2% | 25 |
|
|
2022
Q2 | $2.85M | Buy |
1,026,024
+59,100
| +6% | +$164K | 0.89% | 34 |
|
|
2022
Q1 | $5.53M | Buy |
966,924
+600,920
| +164% | +$3.44M | 1.57% | 30 |
|
|
2021
Q4 | $3.34M | Buy |
366,004
+7,100
| +2% | +$64.8K | 0.98% | 32 |
|
|
2021
Q3 | $3.84M | Hold |
358,904
| – | – | 1.15% | 31 |
|
|
2021
Q2 | $5.57M | Buy |
+358,904
| New | +$5.57M | 1.61% | 31 |
|